By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Waters reported today an 8 percent increase in second-quarter revenues, which the firm partially attributed to "significantly improved" sales to pharmaceutical customers.

For the three months ended July 3, Waters said that revenues rose to $391.1 million, compared to $362.8 million in the year-ago period. Its net income increased 21 percent to $84.9 million, or $0.90 per share, from $70 million, $0.72 per share, in Q2 2009.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.